168
Views
4
CrossRef citations to date
0
Altmetric
Review

Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 373-384 | Published online: 11 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Dejan Jakimovski, Taylor R Wicks, Niels Bergsland, Michael G Dwyer, Bianca Weinstock-Guttman & Robert Zivadinov. (2023) Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis. Degenerative Neurological and Neuromuscular Disease 13, pages 21-32.
Read now
Dejan Jakimovski, Caila B Vaughn, Svetlana Eckert, Robert Zivadinov & Bianca Weinstock-Guttman. (2020) Long-term drug treatment in multiple sclerosis: safety success and concerns. Expert Opinion on Drug Safety 19:9, pages 1121-1142.
Read now

Articles from other publishers (2)

Dejan Jakimovski, Samreen Awan, Svetlana P. Eckert, Osman Farooq & Bianca Weinstock-Guttman. (2021) Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment. CNS Drugs 36:1, pages 45-59.
Crossref
Oliver Neuhaus, Wolfgang Köhler, Florian Then Bergh, Wolfgang Kristoferitsch, Jürgen Faiss, Thorsten Rosenkranz, Dirk Reske, Robert Patejdl, Hans-Peter Hartung & Uwe K. Zettl. (2021) Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue—Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers. Biomolecules 11:3, pages 393.
Crossref